220 related articles for article (PubMed ID: 24115476)
1. A pegylated leptin antagonist ameliorates CKD-associated cachexia in mice.
Cheung WW; Ding W; Gunta SS; Gu Y; Tabakman R; Klapper LN; Gertler A; Mak RH
J Am Soc Nephrol; 2014 Jan; 25(1):119-28. PubMed ID: 24115476
[TBL] [Abstract][Full Text] [Related]
2. A Leptin Receptor Antagonist Attenuates Adipose Tissue Browning and Muscle Wasting in Infantile Nephropathic Cystinosis-Associated Cachexia.
Gonzalez A; Cheung WW; Perens EA; Oliveira EA; Gertler A; Mak RH
Cells; 2021 Jul; 10(8):. PubMed ID: 34440723
[TBL] [Abstract][Full Text] [Related]
3. Preparation of Potent Leptin Receptor Antagonists and Their Therapeutic Use in Mouse Models of Uremic Cachexia and Kidney Fibrosis.
Mak RH; Cheung WW; Solomon G; Gertler A
Curr Pharm Des; 2018; 24(9):1012-1018. PubMed ID: 29366406
[TBL] [Abstract][Full Text] [Related]
4. Exploiting the therapeutic potential of leptin signaling in cachexia.
Mak RH; Cheung WW; Gertler A
Curr Opin Support Palliat Care; 2014 Dec; 8(4):352-7. PubMed ID: 25259544
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D ameliorates adipose browning in chronic kidney disease cachexia.
Cheung WW; Ding W; Hoffman HM; Wang Z; Hao S; Zheng R; Gonzalez A; Zhan JY; Zhou P; Li S; Esparza MC; Lieber RL; Mak RH
Sci Rep; 2020 Aug; 10(1):14175. PubMed ID: 32843714
[TBL] [Abstract][Full Text] [Related]
6. Differential Effects of 25-Hydroxyvitamin D
Mak RH; Querfeld U; Gonzalez A; Gunta S; Cheung WW
Cells; 2021 Dec; 10(12):. PubMed ID: 34943890
[TBL] [Abstract][Full Text] [Related]
7. Melanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease.
Cheung WW; Mak RH
Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1315-24. PubMed ID: 22914778
[TBL] [Abstract][Full Text] [Related]
8. The role of IL-1 in adipose browning and muscle wasting in CKD-associated cachexia.
Cheung WW; Zheng R; Hao S; Wang Z; Gonzalez A; Zhou P; Hoffman HM; Mak RH
Sci Rep; 2021 Jul; 11(1):15141. PubMed ID: 34302016
[TBL] [Abstract][Full Text] [Related]
9. Leptin and inflammation-associated cachexia in chronic kidney disease.
Mak RH; Cheung W; Cone RD; Marks DL
Kidney Int; 2006 Mar; 69(5):794-7. PubMed ID: 16518340
[TBL] [Abstract][Full Text] [Related]
10. Growth Hormone Improves Adipose Tissue Browning and Muscle Wasting in Mice with Chronic Kidney Disease-Associated Cachexia.
Mak RH; Gunta S; Oliveira EA; Cheung WW
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499637
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D repletion ameliorates adipose tissue browning and muscle wasting in infantile nephropathic cystinosis-associated cachexia.
Cheung WW; Hao S; Wang Z; Ding W; Zheng R; Gonzalez A; Zhan JY; Zhou P; Li S; Esparza MC; Hoffman HM; Lieber RL; Mak RH
J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):120-134. PubMed ID: 31721480
[TBL] [Abstract][Full Text] [Related]
12. Long-noncoding RNA Atrolnc-1 promotes muscle wasting in mice with chronic kidney disease.
Sun L; Si M; Liu X; Choi JM; Wang Y; Thomas SS; Peng H; Hu Z
J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):962-974. PubMed ID: 30043444
[TBL] [Abstract][Full Text] [Related]
13. Melanocortin-4 receptor antagonist TCMCB07 ameliorates cancer- and chronic kidney disease-associated cachexia.
Zhu X; Callahan MF; Gruber KA; Szumowski M; Marks DL
J Clin Invest; 2020 Sep; 130(9):4921-4934. PubMed ID: 32544087
[TBL] [Abstract][Full Text] [Related]
14. Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk.
Wu J; Dong J; Verzola D; Hruska K; Garibotto G; Hu Z; Mitch WE; Thomas SS
J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1210-1227. PubMed ID: 31507080
[TBL] [Abstract][Full Text] [Related]
15. Cancer cachexia.
Tisdale MJ
Langenbecks Arch Surg; 2004 Aug; 389(4):299-305. PubMed ID: 15168125
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile.
Deboer MD; Zhu X; Levasseur PR; Inui A; Hu Z; Han G; Mitch WE; Taylor JE; Halem HA; Dong JZ; Datta R; Culler MD; Marks DL
Endocrinology; 2008 Feb; 149(2):827-35. PubMed ID: 18039782
[TBL] [Abstract][Full Text] [Related]
17. Targeting interleukin-1 for reversing fat browning and muscle wasting in infantile nephropathic cystinosis.
Cheung WW; Hao S; Zheng R; Wang Z; Gonzalez A; Zhou P; Hoffman HM; Mak RH
J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1296-1311. PubMed ID: 34196133
[TBL] [Abstract][Full Text] [Related]
18. [Systemic and local mechanisms leading to cachexia in cancer].
Grabiec K; Burchert M; Milewska M; Błaszczyk M; Grzelkowska-Kowalczyk K
Postepy Hig Med Dosw (Online); 2013 Dec; 67():1397-409. PubMed ID: 24493689
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexia.
Asp ML; Tian M; Kliewer KL; Belury MA
Cancer Biol Ther; 2011 Dec; 12(11):957-65. PubMed ID: 22104958
[TBL] [Abstract][Full Text] [Related]
20. The ghrelin receptor agonist HM01 mimics the neuronal effects of ghrelin in the arcuate nucleus and attenuates anorexia-cachexia syndrome in tumor-bearing rats.
Borner T; Loi L; Pietra C; Giuliano C; Lutz TA; Riediger T
Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R89-96. PubMed ID: 27147616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
